Cargando…
Current Understanding of Circulating Tumor Cells – Potential Value in Malignancies of the Central Nervous System
Detection of circulating tumor cells (CTCs) in the blood via so-called “liquid biopsies” carries enormous clinical potential in malignancies of the central nervous system (CNS) because of the potential to follow disease evolution with a blood test, without the need for repeat neurosurgical procedure...
Autores principales: | Adamczyk, Lukasz A., Williams, Hannah, Frankow, Aleksandra, Ellis, Hayley Patricia, Haynes, Harry R., Perks, Claire, Holly, Jeff M. P., Kurian, Kathreena M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530310/ https://www.ncbi.nlm.nih.gov/pubmed/26322014 http://dx.doi.org/10.3389/fneur.2015.00174 |
Ejemplares similares
-
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014) -
Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma
por: Lakin, Natasha, et al.
Publicado: (2017) -
Insulin‐like growth factor binding protein‐2 and glucose‐regulated protein 78 kDa: Potential biomarkers affect prognosis in
IDH
‐wildtype glioblastoma patients
por: Harland, Abigail J., et al.
Publicado: (2023) -
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015) -
Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
por: Haynes, Harry R., et al.
Publicado: (2014)